1-20 of 23
Yan Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 study of MK-1045, a novel CD19xCD3 T-cell engager, in participants with relapsed or refractory follicular lymphoma

Free
Yuqin Song, Ye Guo, Qingqing Cai, Haisheng Liu, Mingxia Wang, Wenrong Huang, Mingzhi Zhang, Lanfang Li, Yanyan Liu, Yuerong Shuang, Zengjun Li, Cuizhen Niu, Andrew Chow, Jingxia Chen, Yan Xie
Journal: Blood
Blood (2025) 146 (Supplement 1): 5372.
https://doi.org/10.1182/blood-2025-5372
Published: 2025
Journal Articles

Clinical characteristics of early mortality and critical illness in acute promyelocytic leukemia patients

Free
Peiqi Liang, Jianhong Fu, Qian Li, Yan Xie, Ziyi Liu, Dong Wang, Meng Gao, Bingqing Li, Depei Wu
Journal: Blood
Blood (2025) 146 (Supplement 1): 6941.
https://doi.org/10.1182/blood-2025-6941
Published: 2025
Journal Articles

Sustained MRD negativity via multimodal NGS/NGF overcomes high-risk cytogenetics and predicts long-term survival in transplant-eligible multiple myeloma: A real-world cohort study

Free
Yuhe Peng, li Yao, Mingqing Zhu, Hongying You, Yan Xie, Zhi Yan, Weiqin Yao, Shuang Yan, Yingying Zhai, Jingjing Shang, Song Jin, Lingzhi Yan, Depei Wu, Chengcheng Fu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5796.
https://doi.org/10.1182/blood-2025-5796
Published: 2025
Journal Articles

Phase 1 study of MK-1045, a novel CD19xCD3 T-cell engager, in participants with relapsed or refractory diffuse large B-cell lymphoma

Free
Yuqin Song, Qingqing Cai, Ye Guo, Haisheng Liu, Mingxia Wang, Wenrong Huang, Mingzhi Zhang, Yanyan Liu, Lanfang Li, Yuerong Shuang, Zengjun Li, Cuizhen Niu, Lin-Chi Chen, Jingxia Chen, Yan Xie
Journal: Blood
Blood (2025) 146 (Supplement 1): 3740.
https://doi.org/10.1182/blood-2025-3740
Published: 2025
Journal Articles

JS203, a CD20×CD3 bispecific antibody, demonstrated promising anti-cancer activity in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL): Updated results from a phase I study

Free
Yan Xie, Hongmei Jing, Yufu Li, Hongming He, Yuerong Shuang, Huangming Hong, Haiyan Yang, Huijing Wu, Liqun Zou, Zengjun Li, Xiaojing Yan, Wei Yang, QI Deng, Hong Cen, Jian Li, Wenyu Li, Zhifang Liu, Hongyan Tong, Li Yu, Yifan Wang, Weiwei Wang, Tong Lu, Shuanghui Wei, Zhihao Jiang, Jianjun Zou, Yuqin Song
Journal: Blood
Blood (2025) 146 (Supplement 1): 1957.
https://doi.org/10.1182/blood-2025-1957
Published: 2025
Journal Articles

Prognosis Prediction and Treatment Recommendation for Follicular Lymphoma: Enhancing Decision-Making

Free
Xinze Li, Jiaxin Liu, Lan Mi, Liantao Ma, Junyi Gao, Yan Xie, Yuqin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 6353.
https://doi.org/10.1182/blood-2024-212407
Published: 2024
Journal Articles

Time Series Deep Neural Network Identifies Lymphoma Patients Suitable for CAR-T Cell Therapy Using EHR Data

Free
Meihua Long, Fan Jia, Jili Deng, Jianing Zhang, Ziran Zhao, Yan Xie, Lan Mi, Yan Hou, Yuqin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 2233.
https://doi.org/10.1182/blood-2024-209699
Published: 2024
Journal Articles

Colistin Methanesulfonate Is Efficacious and Safe for the Management of Sepsis in Hematological Diseases Patients: A Retrospective Study in China

Free
Yan Xie, Ziyi Liu, Peiqi Liang, Depei Wu, Jianhong Fu
Journal: Blood
Blood (2024) 144 (Supplement 1): 5992.
https://doi.org/10.1182/blood-2024-204894
Published: 2024
Journal Articles

Dynamic Single-Cell Profiling Reveals Novel Immune Regulatory Mechanism of ITK Inhibitor Soquelitinib in Refractory T Cell Lymphoma

Free
Ning Ding, Yan Xie, Yong Guo, Kecheng Li, Tingting DU, Zhenjun Li, Yuejiao Li, Jiaowu Cao, Dingyao Hu, Lih-Yun Hsu, Richard Miller, Jun Zhu, Yuqin Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 1442.
https://doi.org/10.1182/blood-2023-174421
Published: 2023
Journal Articles

Venetoclax Combined with Hypomethylating Agents in Acute Myeloid Leukemia Patients Serious Complications Admitted to a Special Hematological Intensive Care Unit

Free
Peiqi Liang, Depei Wu, Yan Xie, Ziyi Liu, Jianhong Fu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5944.
https://doi.org/10.1182/blood-2023-173088
Published: 2023
Journal Articles

Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas

Free
Yuqin Song, JUN MA, Yan Xie, Huilai Zhang, Zhigang Peng, Yuerong Shuang, Fei Li, Yufu Li, Haiyan Yang, Xiuhua Sun, Liqun Zou, Yunhong Huang, Weili Zhao, Wenrong Huang, Hui Zhou, Mingying Liu, Weiwei Wang, Jing Xu, Yajie Wang, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4458.
https://doi.org/10.1182/blood-2023-181385
Published: 2023
Journal Articles

GB261, an Fc-Function Enabled and CD3 Affinity De-Tuned CD20/CD3 Bispecific Antibody, Demonstrated a Highly Advantageous Safety/Efficacy Balance in an Ongoing First-in-Human Dose-Escalation Study in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Free
Yuqin Song, Zengjun Li, Ling Li, Zhengzi Qian, Keshu Zhou, Lei Fan, Peter Tan, Pratyush Giri, Zhiming Li, Melita Kenealy, Jie Jin, Wei Liu, Shafqat Inam, Yan Xie, Xia Guo, Wenduo He, Raymond Xu, Tong Li, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1719.
https://doi.org/10.1182/blood-2023-188444
Published: 2023
Journal Articles

Phase I Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas

Free
Jun Ma, Yuqin Song, Yan Xie, Hui-Lai Zhang, Yuerong Shuang, Zhigang Peng, Li Fei, Yunhong Huang, Weili Zhao, Wenrong Huang, Yali Pan, Mingying Liu, Feiwu Ran, Hui Feng, Sheng Yao, Patricia Keegan, Jianjun Zou, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3716–3717.
https://doi.org/10.1182/blood-2022-157497
Published: 2022
Journal Articles

Targeting 1q21 Amplification with APG2575 and Lenalidomide to Sensitize BCL-2 Inhibition with the Decrease of MCL-1 Protein in High Risk MM Models

Free
Yan Xie, MD, Chengcheng FU, MD PhD, Lingzhi Yan, MD PhD, Song Jin, MD, Jingjing Shang, MD, Xiaolan Shi, MD PhD, Jinlan Pan, MD, Yan Yin, MS, Tingting Mao, MS, Jing Deng, PhD, Douglas D. Fang, MD PhD, Dajun Yang, MD PhD, Yifan Zhai, MD PhD, Shuang Yan, MD, Yingying Zhai, MD, Ying Yao, MD, Panfeng Wang, MD, Jing Wang, MD, Depei Wu, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139195
Published: 2020
Journal Articles

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Free
Zhitao Ying, MD PhD, Wen Wang, MD, Xiaopei Wang, MD, Wen Zheng, MD, Ningjing Lin, MD PhD, Meifeng Tu, MD PhD, Yan Xie, MD PhD, Lingyan Ping, MD PhD, Chen Zhang, MD PhD, Weiping Liu, MD PhD, Lijuan Deng, MD PhD, Ming Hao, Su Yang, Yan Zhou, BSc, James Li, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5388.
https://doi.org/10.1182/blood-2018-99-114527
Published: 2018
Journal Articles

Incidence, Clinical Characteristics and Outcome of Cardiac Toxicity in Elderly Patients with Diffuse Large B-Cell Lymphoma

Free
Wei Ping Liu, Yan Feng Xu, Yan Xie, Xiaopei Wang, MD, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5416.
https://doi.org/10.1182/blood-2018-99-117955
Published: 2018
Journal Articles

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Free
Yalu Liu, Ning Ding, MD, Xiaogan Wang, MD, Lijuan Deng, MD, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Yuqin Song, MD, Jun Zhu, BS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1461.
https://doi.org/10.1182/blood.V130.Suppl_1.1461.1461
Published: 2017
Journal Articles

Efficacy of Lower Dose Rituximab by Adding Fresh Frozen Plasma for the Treatment of Idiopathic Thrombocytopenic Purpura

Free
Mei Sun, JIan Gu, Bin He, Xiao-Yan Xie, Bao-An Chen, MD, PhD, Xiao-Ping Pei
Journal: Blood
Blood (2010) 116 (21): 4682.
https://doi.org/10.1182/blood.V116.21.4682.4682
Published: 2010
Journal Articles

STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease

Free
Geqiang Li, Kristy L. Miskimen, Zhengqi Wang, Xiu Yan Xie, Jennifer Brenzovich, John J. Ryan, William Tse, Richard Moriggl, Kevin D. Bunting
Journal: Blood
Blood (2010) 115 (7): 1416–1424.
https://doi.org/10.1182/blood-2009-07-234963
Published: 2010
Includes: Supplemental data
Journal Articles

Genetic and Pharmacologic Targeting of STAT5/Gab2/PI3K/mTOR Signaling in a Mouse Myeloproliferative Disease Model.

Free
Geqiang Li, Ph.D., Zhengqi Wang, Ph.D., Kristy L. Miskimen, Ph.D., Xiu Yan Xie, M.D., William Tse, M.D., Fabrice Gouilleux, Ph.D., Richard Moriggl, Ph.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 3902.
https://doi.org/10.1182/blood.V114.22.3902.3902
Published: 2009